153 related articles for article (PubMed ID: 17611411)
1. P14ARF sensitizes human osteosarcoma cells to cisplatin-induced apoptosis in a p53-independent manner.
Yuan XW; Zhu XF; Huang XF; Sheng PY; He AS; Yang ZB; Deng R; Feng GK; Liao WM
Cancer Biol Ther; 2007 Jul; 6(7):1074-80. PubMed ID: 17611411
[TBL] [Abstract][Full Text] [Related]
2. [p14ARF enhances cisplatin-induced apoptosis in human osteosarcoma cells in p53-independent pathway].
Huang X; Yuan X; Chen Z; Liang S
Zhonghua Yi Xue Za Zhi; 2015 Sep; 95(35):2875-9. PubMed ID: 26815194
[TBL] [Abstract][Full Text] [Related]
3. [p14ARF enhances chemosensitivity to cisplatin in human osteosarcoma U2OS cells through p53 apoptotic pathway].
Yuan X; Huang X; Chen Z; Liang S; Liao W
Zhonghua Yi Xue Za Zhi; 2014 Nov; 94(43):3443-6. PubMed ID: 25622680
[TBL] [Abstract][Full Text] [Related]
4. Interferonalpha enhances etoposide-induced apoptosis in human osteosarcoma U2OS cells by a p53-dependent pathway.
Yuan XW; Zhu XF; Liang SG; Fan Q; Chen ZX; Huang XF; Sheng PY; He AS; Yang ZB; Deng R; Feng GK; Liao WM
Life Sci; 2008 Feb; 82(7-8):393-401. PubMed ID: 18191951
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis.
Hemmati PG; Gillissen B; von Haefen C; Wendt J; Stärck L; Güner D; Dörken B; Daniel PT
Oncogene; 2002 May; 21(20):3149-61. PubMed ID: 12082630
[TBL] [Abstract][Full Text] [Related]
6. Alterations in the INK4a/ARF locus and their effects on the growth of human osteosarcoma cell lines.
Park YB; Park MJ; Kimura K; Shimizu K; Lee SH; Yokota J
Cancer Genet Cytogenet; 2002 Mar; 133(2):105-11. PubMed ID: 11943335
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis induced by adenovirus-mediated p14ARF expression in U2OS osteosarcoma cells is associated with increased Fas expression.
Kim M; Sgagias M; Deng X; Jung YJ; Rikiyama T; Lee K; Ouellette M; Cowan K
Biochem Biophys Res Commun; 2004 Jul; 320(1):138-44. PubMed ID: 15207713
[TBL] [Abstract][Full Text] [Related]
8. p21 overexpression sensitizes osteosarcoma U2OS cells to cisplatin via evoking caspase-3 and Bax/Bcl-2 cascade.
Ding Y; Wang Y; Chen J; Hu Y; Cao Z; Ren P; Zhang Y
Tumour Biol; 2014 Apr; 35(4):3119-23. PubMed ID: 24323562
[TBL] [Abstract][Full Text] [Related]
9. Theabrownin triggers DNA damage to suppress human osteosarcoma U2OS cells by activating p53 signalling pathway.
Jin W; Zhou L; Yan B; Yan L; Liu F; Tong P; Yu W; Dong X; Xie L; Zhang J; Xu Y; Li C; Yuan Q; Shan L; Efferth T
J Cell Mol Med; 2018 Sep; 22(9):4423-4436. PubMed ID: 29993186
[TBL] [Abstract][Full Text] [Related]
10. Limited role of N-terminal phosphoserine residues in the activation of transcription by p53.
Jackson MW; Agarwal MK; Agarwal ML; Agarwal A; Stanhope-Baker P; Williams BR; Stark GR
Oncogene; 2004 May; 23(25):4477-87. PubMed ID: 15064747
[TBL] [Abstract][Full Text] [Related]
11. Metformin inhibits growth and sensitizes osteosarcoma cell lines to cisplatin through cell cycle modulation.
Quattrini I; Conti A; Pazzaglia L; Novello C; Ferrari S; Picci P; Benassi MS
Oncol Rep; 2014 Jan; 31(1):370-5. PubMed ID: 24253938
[TBL] [Abstract][Full Text] [Related]
12. Azidothymidine and cisplatin increase p14ARF expression in OVCAR-3 ovarian cancer cell line.
Vaskivuo L; Rysä J; Koivuperä J; Myllynen P; Vaskivuo T; Chvalova K; Serpi R; Savolainen ER; Puistola U; Vähäkangas K
Toxicol Appl Pharmacol; 2006 Oct; 216(1):89-97. PubMed ID: 16797627
[TBL] [Abstract][Full Text] [Related]
13. Lack of p53 augments thymoquinone-induced apoptosis and caspase activation in human osteosarcoma cells.
Roepke M; Diestel A; Bajbouj K; Walluscheck D; Schonfeld P; Roessner A; Schneider-Stock R; Gali-Muhtasib H
Cancer Biol Ther; 2007 Feb; 6(2):160-9. PubMed ID: 17218778
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin induces apoptosis via upregulating Wrap53 in U-2OS osteosarcoma cells.
Yuan JM; Li XD; Liu ZY; Hou GQ; Kang JH; Huang DY; Du SX
Asian Pac J Cancer Prev; 2011; 12(12):3465-9. PubMed ID: 22471498
[TBL] [Abstract][Full Text] [Related]
15. Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway.
Spina A; Sorvillo L; Di Maiolo F; Esposito A; D'Auria R; Di Gesto D; Chiosi E; Naviglio S
J Cell Physiol; 2013 Jan; 228(1):198-206. PubMed ID: 22674530
[TBL] [Abstract][Full Text] [Related]
16. Ras-mediated activation of ERK by cisplatin induces cell death independently of p53 in osteosarcoma and neuroblastoma cell lines.
Woessmann W; Chen X; Borkhardt A
Cancer Chemother Pharmacol; 2002 Nov; 50(5):397-404. PubMed ID: 12439598
[TBL] [Abstract][Full Text] [Related]
17. The p33ING1b tumor suppressor cooperates with p53 to induce apoptosis in response to etoposide in human osteosarcoma cells.
Zhu JJ; Li FB; Zhu XF; Liao WM
Life Sci; 2006 Feb; 78(13):1469-77. PubMed ID: 16325212
[TBL] [Abstract][Full Text] [Related]
18. [Interferon α sensitizes human osteosarcoma cells to doxorubicin-induced apoptosis through p53-dependent pathway].
Yuan XW; Huang XF; Chen ZX; Liang SG; Liao WM
Zhonghua Yi Xue Za Zhi; 2016 Oct; 96(37):3008-3013. PubMed ID: 27760664
[No Abstract] [Full Text] [Related]
19. Platinum agents in the treatment of osteosarcoma: efficacy of cisplatin vs. carboplatin in human osteosarcoma cell lines.
Robson H; Meyer S; Shalet SM; Anderson E; Roberts S; Eden OB
Med Pediatr Oncol; 2002 Dec; 39(6):573-80. PubMed ID: 12376980
[TBL] [Abstract][Full Text] [Related]
20. Recombinant adenovirus-mediated p14(ARF) overexpression sensitizes human breast cancer cells to cisplatin.
Deng X; Kim M; Vandier D; Jung YJ; Rikiyama T; Sgagias MK; Goldsmith M; Cowan KH
Biochem Biophys Res Commun; 2002 Aug; 296(4):792-8. PubMed ID: 12200117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
